You have 9 free searches left this month | for more free features.

Antibodies, Monoclonal

Showing 1 - 25 of 7,565

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)

Completed
  • Clostridium Infection
  • Collection of peripheral blood mononuclear cells
  • Paris, France
    Maladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022

Solid Tumor, Adult Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Solid Tumor, Adult
  • Hackensack, New Jersey
  • +3 more
Apr 14, 2022

Isolation of Human Recombinant Therapeutic Monoclonal

Recruiting
  • Pseudomonas Aeruginosa
  • Multi-antibiotic Resistance
  • Isolation of anti-Pseudomonas antibodies from type B lymphocytes
  • Grenoble, France
    Chu Grenoble Alpes
May 6, 2022

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

Recruiting
  • Immunocompromised Patients
  • Data collection
  • Paris, Ile De France, France
    Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022

Headache, Migraine Trial in Chicago, Naperville (Ubrogepant 50 MG [Ubrelvy], Ubrogepant 100 MG [Ubrelvy])

Not yet recruiting
  • Headache, Migraine
  • Ubrogepant 50 MG [Ubrelvy]
  • Ubrogepant 100 MG [Ubrelvy]
  • Chicago, Illinois
  • +1 more
Aug 14, 2022

Against BK Virus Infection Based on Monoclonal Antibodies

Not yet recruiting
  • BK Virus Infection
    • Strasbourg, France
      Service de Virologie - CHU Strasbourg - France
    Feb 21, 2022

    Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

    Completed
    • Solid Tumor, Adult
    • Minneapolis, Minnesota
    • +2 more
    Jan 27, 2023

    Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

    Recruiting
    • Migraine
    • +4 more
    • Innsbruck, Tirol, Austria
    • +2 more
    Oct 19, 2022

    Monoclonal Antibodies (Sotrovimab )

    Recruiting
    • COVID-19 Respiratory Infection
      • Dubai, United Arab Emirates
        Emirats Health Service
      Dec 13, 2021

      Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)

      Not yet recruiting
      • Allergic Rhinitis
      • Conjunctivitis
      • (no location specified)
      Jun 20, 2022

      COVID-19 Trial in Hong Kong (BRII-196 and BRII-198, Placebo)

      Withdrawn
      • COVID-19
      • BRII-196 and BRII-198
      • Placebo
      • Hong Kong, China
        Investigative Site 1
      Mar 1, 2022

      SURvival of SEzary Syndrome Over 1998-2020 Period and Its

      Not yet recruiting
      • Sezary Syndrome
      • Cutaneous T Lymphoma
      • Standard of care
      • Paris, France
        Hôpital Saint-Louis, Service de Dermatologie
      Jan 24, 2022

      Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

      Recruiting
      • Infusion Reaction
      • Monoclonal Antibody
      • Montelukast 10 Mg Oral Tablet
      • Clovis, California
        Community Cancer Institute
      Nov 8, 2021

      COVID-19 Trial in Beijing (BRII-196 and BRII-198, Placebo)

      Completed
      • COVID-19
      • BRII-196 and BRII-198
      • Placebo
      • Beijing, Beijing, China
        Investigative Site
      Mar 1, 2022

      Acquiring Convalescent Specimens for COVID-19 Antibodies

      Completed
      • COVID-19
      • +2 more
      • Blood draw
      • New York, New York
        Columbia University Irving Medical Center/NYP
      Jul 18, 2022

      Covid19 Trial in Edinburg, Rio Grande City (BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB)

      Recruiting
      • Covid19
      • BAMLANIVIMAB
      • +2 more
      • Edinburg, Texas
      • +2 more
      Mar 14, 2022

      Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

      Recruiting
      • Non Small Cell Lung Cancer
      • +6 more
      • Scottsdale, Arizona
      • +4 more
      Dec 27, 2022

      Healthy, Chronic Stable Illness Trial in Miami, Winter Park (Casirivimab+Imdevimab)

      Completed
      • Healthy
      • Chronic Stable Illness
      • Miami, Florida
      • +1 more
      Jun 15, 2022

      COVID-19 : Neutralizing Human Monoclonal Antibodies Against

      Completed
      • COVID
      • Blood sample
      • Lyon, France
        Hôpital de la Croix-Rousse
      Jun 17, 2021

      Consistency of PD-L1 Detecting Method Between E1L3N and 22C3

      Completed
      • Non Small Cell Lung Cancer
        • Changsha, Hunan, China
          Hunan Cancer Hospital
        Nov 20, 2021

        TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use

        Recruiting
        • COVID-19
        • casirivimab with imdevimab
        • +2 more
        • Amsterdam, Noord Holland, Netherlands
        • +3 more
        Jan 13, 2022

        COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

        Suspended
        • COVID-19 Infection
        • +2 more
        • Questionnaire Administration
        • Sotrovimab
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Jan 24, 2023

        COVID-19 Trial in Stony Brook, Memphis (casirivimab+imdevimab)

        Terminated
        • COVID-19
        • Stony Brook, New York
        • +1 more
        Jul 26, 2022

        COVID-19 Trial in China (BRII-196 and BRII-198, Placebo)

        Completed
        • COVID-19
        • BRII-196 and BRII-198
        • Placebo
        • Beijing, Beijing, China
        • +5 more
        Mar 1, 2022

        Breast Cancer Trial in Besançon (additional blood sample)

        Completed
        • Breast Cancer
        • additional blood sample
        • Besançon, France
          Centre Hospitalier Régional Universitaire
        Apr 15, 2021